Novartis Ag (NVS) Total Debt (2009 - 2026)

Novartis Ag has disclosed Total Debt across 18 years of filings, most recently posting $9.6 billion for Q2 2026.

• In Q2 2026, Total Debt rose 15.32% year-over-year to $9.6 billion; the TTM figure through Jun 2026 stood at $9.6 billion (up 15.32% YoY), while the FY2025 annual figure was $6.3 billion, down 29.19% from the prior year.
• Total Debt came in at $9.6 billion for Q2 2026 at Novartis Ag, up from $7.6 billion in the prior quarter.
• In the past five years, Total Debt ranged from a high of $9.6 billion in Q2 2026 to a low of $5.5 billion in Q3 2023.
• Average Total Debt over 5 years is $7.4 billion, with a median of $7.3 billion recorded in 2022.
• Year-over-year, Total Debt sank 34.13% in 2022 and surged 30.52% in 2024.
• Over 5 years, Total Debt stood at $6.8 billion in 2022, then gained by 0.07% to $6.8 billion in 2023, then soared by 30.52% to $8.9 billion in 2024, then dropped by 29.19% to $6.3 billion in 2025, then surged by 52.58% to $9.6 billion in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $9.6 billion in Q2 2026, $7.6 billion in Q1 2026, and $6.3 billion in Q4 2025.